Home  >  Products  >  LMO2 (LIM domain only 2 (rhombotin-like 1)) Blocking Peptide (the N terminal of protein) (100ug)
LMO2 (LIM domain only 2 (rhombotin-like 1)) Blocking Peptide (the N terminal of protein) (100ug)

LMO2 (LIM domain only 2 (rhombotin-like 1)) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LMO2 antibody (Catalogue #: P100952_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP31307
Size: 100 ug
Weight: 18kDa
Gene: 4005
Format: Lyophilized powder
Target: LMO2 acts with TAL1/SCL to regulate red blood cell development. LMO2 also acts with LDB1 to maintain erythroid precursors in an immature state.LMO2 encodes a cysteine-rich, two LIM-domain protein that is required for yolk sac erythropoiesis. The LMO2 protein has a central and crucial role in hematopoietic development and is highly conserved. The LMO2 transcription start site is located approximately 25 kb downstream from the 11p13 T-cell translocation cluster (11p13 ttc), where a number T-cell acute lymphoblastic leukemia-specific translocations occur. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: RBTN2; RBTNL1; RHOM2; TTG2
See Full Product Listings >